BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 35526650)

  • 21. Inhibition of ERK1/2 in cancer-associated pancreatic stellate cells suppresses cancer-stromal interaction and metastasis.
    Yan Z; Ohuchida K; Fei S; Zheng B; Guan W; Feng H; Kibe S; Ando Y; Koikawa K; Abe T; Iwamoto C; Shindo K; Moriyama T; Nakata K; Miyasaka Y; Ohtsuka T; Mizumoto K; Hashizume M; Nakamura M
    J Exp Clin Cancer Res; 2019 May; 38(1):221. PubMed ID: 31133044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pancreatic Stellate Cells Promote Tumor Progression by Promoting an Immunosuppressive Microenvironment in Murine Models of Pancreatic Cancer.
    Li C; Cui L; Yang L; Wang B; Zhuo Y; Zhang L; Wang X; Zhang Q; Zhang S
    Pancreas; 2020 Jan; 49(1):120-127. PubMed ID: 31856087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies.
    Haqq J; Howells LM; Garcea G; Metcalfe MS; Steward WP; Dennison AR
    Eur J Cancer; 2014 Oct; 50(15):2570-82. PubMed ID: 25091797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ERAP2 is a novel target involved in autophagy and activation of pancreatic stellate cells via UPR signaling pathway.
    Guan W; Nakata K; Sagara A; Iwamoto C; Endo S; Matsuda R; Matsumoto S; Ikenaga N; Shindo K; Moriyama T; Onishi H; Ohuchida K; Oda Y; Nakamura M
    Pancreatology; 2022 Jan; 22(1):9-19. PubMed ID: 34642112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion.
    Sousa CM; Biancur DE; Wang X; Halbrook CJ; Sherman MH; Zhang L; Kremer D; Hwang RF; Witkiewicz AK; Ying H; Asara JM; Evans RM; Cantley LC; Lyssiotis CA; Kimmelman AC
    Nature; 2016 Aug; 536(7617):479-83. PubMed ID: 27509858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GPR68, a proton-sensing GPCR, mediates interaction of cancer-associated fibroblasts and cancer cells.
    Wiley SZ; Sriram K; Liang W; Chang SE; French R; McCann T; Sicklick J; Nishihara H; Lowy AM; Insel PA
    FASEB J; 2018 Mar; 32(3):1170-1183. PubMed ID: 29092903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamic mast cell-stromal cell interactions promote growth of pancreatic cancer.
    Ma Y; Hwang RF; Logsdon CD; Ullrich SE
    Cancer Res; 2013 Jul; 73(13):3927-37. PubMed ID: 23633481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cold Atmospheric Plasma Does Not Affect Stellate Cells Phenotype in Pancreatic Cancer Tissue in Ovo.
    Privat-Maldonado A; Verloy R; Cardenas Delahoz E; Lin A; Vanlanduit S; Smits E; Bogaerts A
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenvironment of pancreatic ductal adenocarcinoma.
    Li X; Lee Y; Kang Y; Dai B; Perez MR; Pratt M; Koay EJ; Kim M; Brekken RA; Fleming JB
    Cell Death Differ; 2019 Jan; 26(2):382-393. PubMed ID: 30283082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic stellate cell: Pandora's box for pancreatic disease biology.
    Bynigeri RR; Jakkampudi A; Jangala R; Subramanyam C; Sasikala M; Rao GV; Reddy DN; Talukdar R
    World J Gastroenterol; 2017 Jan; 23(3):382-405. PubMed ID: 28210075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The P2X7 Receptor Stimulates IL-6 Release from Pancreatic Stellate Cells and Tocilizumab Prevents Activation of STAT3 in Pancreatic Cancer Cells.
    Magni L; Bouazzi R; Heredero Olmedilla H; Petersen PSS; Tozzi M; Novak I
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic Strategies Toward Lactate Dehydrogenase Within the Tumor Microenvironment of Pancreatic Cancer.
    Moir JAG; Long A; Haugk B; French JJ; Charnley RM; Manas DM; Wedge SR; Mann J; Robinson SM; White SA
    Pancreas; 2020; 49(10):1364-1371. PubMed ID: 33122526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer.
    Mace TA; Shakya R; Pitarresi JR; Swanson B; McQuinn CW; Loftus S; Nordquist E; Cruz-Monserrate Z; Yu L; Young G; Zhong X; Zimmers TA; Ostrowski MC; Ludwig T; Bloomston M; Bekaii-Saab T; Lesinski GB
    Gut; 2018 Feb; 67(2):320-332. PubMed ID: 27797936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel Nonsecosteroidal Vitamin D Receptor Modulator Combined with Gemcitabine Enhances Pancreatic Cancer Therapy through Remodeling of the Tumor Microenvironment.
    Kang Z; Wang C; Tong Y; Li Y; Gao Y; Hou S; Hao M; Han X; Wang B; Wang Q; Zhang C
    J Med Chem; 2021 Jan; 64(1):629-643. PubMed ID: 33381963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrin α11 in pancreatic stellate cells regulates tumor stroma interaction in pancreatic cancer.
    Schnittert J; Bansal R; Mardhian DF; van Baarlen J; Östman A; Prakash J
    FASEB J; 2019 May; 33(5):6609-6621. PubMed ID: 30808244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracellular lumican augments cytotoxicity of chemotherapy in pancreatic ductal adenocarcinoma cells via autophagy inhibition.
    Li X; Roife D; Kang Y; Dai B; Pratt M; Fleming JB
    Oncogene; 2016 Sep; 35(37):4881-90. PubMed ID: 26876211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transforming Growth Factor-β Limits Secretion of Lumican by Activated Stellate Cells within Primary Pancreatic Adenocarcinoma Tumors.
    Kang Y; Roife D; Lee Y; Lv H; Suzuki R; Ling J; Rios Perez MV; Li X; Dai B; Pratt M; Truty MJ; Chatterjee D; Wang H; Thomas RM; Wang Y; Koay EJ; Chiao PJ; Katz MH; Fleming JB
    Clin Cancer Res; 2016 Oct; 22(19):4934-4946. PubMed ID: 27126993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Stromal Lysolipid-Autotaxin Signaling Axis Promotes Pancreatic Tumor Progression.
    Auciello FR; Bulusu V; Oon C; Tait-Mulder J; Berry M; Bhattacharyya S; Tumanov S; Allen-Petersen BL; Link J; Kendsersky ND; Vringer E; Schug M; Novo D; Hwang RF; Evans RM; Nixon C; Dorrell C; Morton JP; Norman JC; Sears RC; Kamphorst JJ; Sherman MH
    Cancer Discov; 2019 May; 9(5):617-627. PubMed ID: 30837243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/ESE3 signalling axis.
    Zhao T; Xiao D; Jin F; Sun X; Yu J; Wang H; Liu J; Cai W; Huang C; Wang X; Gao S; Liu Z; Yang S; Gao C; Hao J
    Br J Cancer; 2022 Nov; 127(8):1461-1472. PubMed ID: 35986089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BAG3-positive pancreatic stellate cells promote migration and invasion of pancreatic ductal adenocarcinoma.
    Yuan Y; Jiang JY; Wang JM; Sun J; Li C; Liu BQ; Yan J; Meng XN; Wang HQ
    J Cell Mol Med; 2019 Aug; 23(8):5006-5016. PubMed ID: 31119886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.